BeiGene ends its Phase 3 lung cancer trial for ociperlimab after a futility analysis. No new safety concerns were found, and study results will be shared later.

This article examines post-market drug safety, highlighting surveillance mechanisms, regulatory responses, and case studies of approved drugs with hidden risks.

The Trump administration carved out an exception for pharmaceuticals from the president's new tariff regime, at least for now ...

According to a factsheet published by the Trump administration, pharmaceuticals are exempted from the tariffs – for now.

Bernstein analyst Courtney Breen maintained a Hold rating on Merck & Company (MRK – Research Report) yesterday and set a price target of ...

Pfizer in 2019 sold $20 billion of drugs in the U.S. Its federal tax bill? Zero. That revelation was part of a Senate Finance ...

The owners of what was once Pennsylvania’s biggest coal-fired power plant said Wednesday that they will turn it into a $10 ...

With concerns mounting and speculation swirling, the particulars of President Donald Trump’s much-touted “Liberation Day” ...

Merck, Hackensack Meridian and Atlantic Health were the only N.J. businesses to make Fortune's list of the country's best companies to work.

Some of the country's largest drugmakers could be impacted by President Donald Trump's reciprocal tariffs, announced on ...

According to Benzinga Pro, Merck & Co's peer group average for short interest as a percentage of float is 4.19%, which means ...